The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial

Cindy L. Amundsen, Holly E. Richter, Shawn Menefee, Sandip Vasavada, David D. Rahn, Kim Kenton, Heidi S. Harvie, Dennis Wallace, Susie Meikle

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial'. Together they form a unique fingerprint.

Medicine & Life Sciences